Dr. Tohru Minamino is well-known for his breakthrough in vascular biology and ageing. A review article led to the comprehensive study of telomeres, telomerase and vascular ageing. Previously, telomeres were studied on cancer cells only. It was Dr. Tohru who for the first time at the laboratory of Harvard Medical School conducted the research on blood vessels, which took 20 years!
Cardiologist & Vascular Ageing
Dr. Tohru Minamino is a cardiologist, currently the Professor and Chairman of the Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine. He is also the Director of Cardiovascular Medicine at Juntendo University Hospital. He received his MD from the Chiba University Graduate School of Medicine in 1989 and his PhD from the Faculty of Medicine, the University of Tokyo in 1997. Furthermore, he is also a research scientist and focuses on molecular mechanisms of ageing. His research interests have currently been growing in the biology of ageing including metabolic pathways of longevity and senolysis. He has published more than 100 papers in journals including Nature, Nature Medicine, Cell, Cell Metabolism, and Lancet. Dr. Minamino has won several awards including the Satoh Memorial Award in the Japanese Circulation Society, and the Erwin von Bälz Award.
After thorough research and immense hard work, Dr. Tohru Minamino was able to formulate an anti-ageing vaccine. However, many people are unaware that Dr. Tohru wanted to become a family physician but, during his career, he developed an interest in medical science.
Dr. Tohru does not regret his choice of becoming a doctor. He puts in all his efforts toward his field, knowing that he will surely get something in return for it, other than his salary. He works for the satisfaction and appreciation he receives from his patients.
Appreciation & Improvement of Healthcare
A doctor’s life is very intriguing because it is filled with moments of fulfilment. Each day is the beginning of a new chapter for them that leads to new discoveries and innovations. Be it day-to-day patient care or becoming the reason behind the improvement in healthcare. Doctors always have something to look forward to.
Off-time is Family-time
Dr. Tohru Minamino finds utmost pleasure in spending time with his family. Even though they go home exhausted, seeing their family at the end of the day is very calming, enabling them to plan their next day with ease.
Challenge of Cardiovascular Diseases
Congestive Heart Failure (CHF) is the most common cause of hospitalisation in people over the age of 65. Although the prognosis of CHF is unclear, this typical cardiovascular condition causes several complications that ultimately lead to the death of a patient. Unfortunately, heart failure has no cure. According to Dr. Tohru Minamino, as a cardiologist, this is the biggest challenge he faces in his career.
Anti-ageing Vaccine against Zombie Cells
In Japan, Dr. Tohru Minamino’s team successfully developed an anti-ageing vaccine. This vaccine tends to work against senescent cells. Cellular senescence refers to the cessation of cell division, therefore, causing ageing. With ageing, senescent cells or zombie cells accumulate refusing to die even when they no longer divide. These cells secrete harmful chemicals that trigger the onset of diabetes, osteoporosis, atherosclerosis, and Alzheimer’s disease. Dr. Tohru’s research was widely acknowledged and appreciated. It was published in the Nature Ageing Journal.
Author of 100+ Research Articles
Dr. Tohru Minamino is the mind behind the anti-ageing vaccine that revolutionises vascular ageing. Beginning research in an unpopular area of interest indicates his devotion to the process, progress and outcome. The advent of the anti-ageing vaccine gives Dr. Tohru a permanent status in medical science.